Skip to main content
    C

    Century Therapeutics Inc (IPSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.37
    -0.27 (-16.46%)

    Market Cap: $297.82M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    Century Therapeutics Inc (IPSC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Century Therapeutics (IPSC) has a market cap of $297.82M and an enterprise value of $252.80M. Its share count is up 138.76% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 15.12% below the market cap, as cash exceeds debt.

    Market Cap$297.82M
    Enterprise Value$252.80M
    Latest price (Nov 17, 2026)$1.37

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.32% in the quarter ended Sep 30, 2026 and grew 56.11% a year over 2 years.

    Shares Outstanding206.44M
    Shares Change (YoY)+138.76%
    Shares Change (QoQ)+0.32%
    Share Count Growth (2Y CAGR)+56.11%

    Valuation Ratios

    P/B Ratio1.3x
    P/TBV Ratio1.6x

    Price Statistics

    The stock is up 190.07% over 52 weeks and trades 15.43% below its 50-day average.

    Beta (1Y)2.19
    52-Week Change+190.07%
    1-Month Change-6.80%
    3-Month Change-35.07%
    6-Month Change-35.38%
    5-Year Change-93.46%
    Total Return (1Y)+190.07%
    Total Return (3Y CAGR)-0.24%
    Total Return (5Y CAGR)-42.06%
    Max Drawdown (1Y)-56.46%
    Max Drawdown (3Y)-92.68%
    Sharpe Ratio (1Y)1.06
    Correlation with SPY (1Y)0.31
    50-Day Average$1.62
    200-Day Average$2.06
    52-Week Range$0.46 to $3.04
    RSI (14 Days)40.5
    Average Volume (20 Days)952.05K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 8.74x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio8.74x
    Quick Ratio8.74x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -47.07% over the last 12 months, against a 5-year average of -45.17%.

    Return on Equity (ROE)-47.07%
    Return on Assets (ROA)-37.63%
    ROE (5Y Average)-45.17%
    ROA (5Y Average)-25.37%
    ROIC (5Y Average)-25.33%

    Scores

    IPSC has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$3.55M
    Operating Income-$106.07M
    Pretax Income-$19.25M
    Net Income-$98.83M
    Reported EPS (TTM)-$0.64

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 79.95% of the $262.63M in total assets.

    Cash and Equivalents$45.02M
    Total Debt$0
    Net Cash$45.02M
    Net Cash Per Share$0.22
    Working Capital$108.67M
    Shareholder Equity$209.97M
    Book Value Per Share$1.02
    Tangible Book Value$175.77M
    Tangible Book Per Share$0.85
    Total Assets$262.63M
    Total Liabilities$52.66M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.95M of capital spending, operating cash flow left -$85.35M of free cash flow.

    Operating Cash Flow-$83.40M
    Capital Expenditures$1.95M
    Free Cash Flow-$85.35M
    FCF Per Share-$0.47
    Depreciation and Amortization$12.13M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Revenue grew 175.88% a year over 3 years.

    Revenue Growth (3Y CAGR)+175.88%
    Book Value Per Share Growth (2Y CAGR)-22.85%
    Tangible Book Per Share Growth (2Y CAGR)-31.66%

    Revenue and profit by year

    Dividends and Yields

    IPSC does not pay a dividend. Its free cash flow yield is -30.18%.

    FCF Yield-30.18%
    Buyback Yield-0.24%
    Shareholder Yield-0.24%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About IPSC

    What is IPSC's market cap?

    Century Therapeutics has a market cap of $297.82M. Its enterprise value, which adds debt and subtracts cash, is $252.80M.

    How many shares of IPSC are outstanding?

    Century Therapeutics has 206.44M shares outstanding. The count is up 138.76% from a year earlier.

    Does IPSC pay a dividend?

    No. Century Therapeutics does not pay a dividend.

    How much debt does IPSC have?

    Century Therapeutics has $0 of total debt and $45.02M of cash and equivalents, a net cash position of $45.02M.